Baclofen-induced encephalopathy in patient with end stage renal disease: Two case reports

We report two end stage renal disease (ESRD) patients, who rapidly developed neurotoxicity after taking baclofen, a centrally acting gamma-aminobutyric acid agonist. They presented to our hospital in a state of confusion. On physical examination, there were no focal neurological deficits and the rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Mousavi, S. S. Beladi, Mousavi, M. Beladi, Motemednia, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459527/
https://www.ncbi.nlm.nih.gov/pubmed/23087558
http://dx.doi.org/10.4103/0971-4065.98762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459527/
https://www.ncbi.nlm.nih.gov/pubmed/23087558
http://dx.doi.org/10.4103/0971-4065.98762

Ejemplares similares